BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20072943)

  • 21. Receptor tyrosine kinase inhibitors as anti-angiogenic agents.
    Kim DW; Lu B; Hallahan DE
    Curr Opin Investig Drugs; 2004 Jun; 5(6):597-604. PubMed ID: 15242247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Novel angiogenesis inhibitors for molecular target therapy of cancer].
    Osada H; Kakeya H
    Nihon Rinsho; 2004 Jul; 62(7):1257-63. PubMed ID: 15283141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of angiogenesis in rheumatoid arthritis].
    Pałgan K
    Postepy Hig Med Dosw; 2000; 54(6):855-65. PubMed ID: 11227381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Angiogenesis and anti-angiogenic strategies for glioblastoma].
    de Boüard S; Guillamo JS
    Bull Cancer; 2005 Apr; 92(4):360-72. PubMed ID: 15888393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis in chronic liver disease and its complications.
    Coulon S; Heindryckx F; Geerts A; Van Steenkiste C; Colle I; Van Vlierberghe H
    Liver Int; 2011 Feb; 31(2):146-62. PubMed ID: 21073649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-angiogenic gene therapy for cancer (review).
    Isayeva T; Kumar S; Ponnazhagan S
    Int J Oncol; 2004 Aug; 25(2):335-43. PubMed ID: 15254730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
    Sato Y
    Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular predictors of response to antiangiogenesis therapies.
    Gerger A; LaBonte M; Lenz HJ
    Cancer J; 2011; 17(2):134-41. PubMed ID: 21427557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translating angiogenesis research into the clinic: the challenges ahead.
    Augustin HG
    Br J Radiol; 2003; 76 Spec No 1():S3-10. PubMed ID: 15456709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-angiogenic therapy: adapting strategies to overcome resistant tumors.
    Mitchell DC; Bryan BA
    J Cell Biochem; 2010 Oct; 111(3):543-53. PubMed ID: 20626031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiating oncolytic viruses by targeted drug intervention.
    Mahoney DJ; Stojdl DF
    Curr Opin Mol Ther; 2010 Aug; 12(4):394-402. PubMed ID: 20677090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy.
    Pasqualetti G; Danesi R; Del Tacca M; Bocci G
    Pharmacogenomics; 2007 Jan; 8(1):49-66. PubMed ID: 17187509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-angiogenic therapy in pediatric brain tumors: an effective strategy?
    Sie M; den Dunnen WF; Hoving EW; de Bont ES
    Crit Rev Oncol Hematol; 2014 Mar; 89(3):418-32. PubMed ID: 24169416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.
    Gacche RN; Meshram RJ
    Biochim Biophys Acta; 2014 Aug; 1846(1):161-79. PubMed ID: 24836679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology of tumor neovascularization.
    Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
    Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenic signaling pathways and anti-angiogenic therapy for cancer.
    Liu ZL; Chen HH; Zheng LL; Sun LP; Shi L
    Signal Transduct Target Ther; 2023 May; 8(1):198. PubMed ID: 37169756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-6: an angiogenic target in solid tumours.
    Middleton K; Jones J; Lwin Z; Coward JI
    Crit Rev Oncol Hematol; 2014 Jan; 89(1):129-39. PubMed ID: 24029605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases.
    Fallah A; Sadeghinia A; Kahroba H; Samadi A; Heidari HR; Bradaran B; Zeinali S; Molavi O
    Biomed Pharmacother; 2019 Feb; 110():775-785. PubMed ID: 30554116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor angiogenesis and anti-angiogenic therapy.
    Kubota Y
    Keio J Med; 2012; 61(2):47-56. PubMed ID: 22760023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of flavonoids as potential modulators of cancer neovascularity.
    Liskova A; Koklesova L; Samec M; Varghese E; Abotaleb M; Samuel SM; Smejkal K; Biringer K; Petras M; Blahutova D; Bugos O; Pec M; Adamkov M; Büsselberg D; Ciccocioppo R; Adamek M; Rodrigo L; Caprnda M; Kruzliak P; Kubatka P
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3079-3096. PubMed ID: 32902794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.